1. 2023
  2. Using brain cell-type-specific protein interactomes to interpret neurodevelopmental genetic signals in schizophrenia

    Wellcome Trust Case-Control Consortium, Schizophrenia Working Group of the Psychiatric Genomics Consortium, Psychosis Endophenotypes International Consortium & Stanley Global Asia Initiatives, 19 May 2023, In: iScience. 26, 5, 106701.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Associations between genetic liabilities to smoking behavior and schizophrenia symptoms in patients with a psychotic disorder, their siblings and healthy controls

    Genetic Risk And Outcome Of Psychosis (Group) Investigators, 1 May 2023, In: Psychiatry research. 323, 115143.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Personal recovery suits us all: A study in patients with non-affective psychosis, unaffected siblings and healthy controls

    van Eck, R. M., van Velden, J., Vellinga, A., van der Krieke, L., Castelein, S., de Haan, L., Schirmbeck, F., van Amelsvoort, T., Bartels-Velthuis, A. A., Bruggeman, R., Cahn, W., Simons, C. J. P. & van Os, J., 1 May 2023, In: Schizophrenia research. 255, p. 24-32 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Serum immune markers and transition to psychosis in individuals at clinical high risk

    EU GEI High Risk Study, 1 May 2023, In: Brain, behavior, and immunity. 110, p. 290-296 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  6. Large-scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortium

    Schijven, D., Postema, M. C., Fukunaga, M., Matsumoto, J., Miura, K., de Zwarte, S. M. C., van Haren, N. E. M., Cahn, W., Hulshoff Pol, H. E., Kahn, R. S., Ayesa-Arriola, R., Ortiz-García de la Foz, V. C., Tordesillas-Gutierrez, D., Vázquez-Bourgon, J., Crespo-Facorro, B., Alnæs, D., Dahl, A., Westlye, L. T., Agartz, I., Andreassen, O. A., & 129 othersJönsson, E. G., Kochunov, P., Bruggemann, J. M., Catts, S. V., Michie, P. T., Mowry, B. J., Quidé, Y., Rasser, P. E., Schall, U., Scott, R. J., Carr, V. J., Green, M. J., Henskens, F. A., Loughland, C. M., Pantelis, C., Weickert, C. S., Weickert, T. W., de Haan, L., Brosch, K., Pfarr, J-K., Ringwald, K. G., Stein, F., Jansen, A., Kircher, T. T. J., Nenadić, I., Krämer, B., Gruber, O., Satterthwaite, T. D., Bustillo, J., Mathalon, D. H., Preda, A., Calhoun, V. D., Ford, J. M., Potkin, S. G., Chen, J., Tan, Y., Wang, Z., Xiang, H., Fan, F., Bernardoni, F., Ehrlich, S., Fuentes-Claramonte, P., Garcia-Leon, M. A., Guerrero-Pedraza, A., Salvador, R., Sarró, S., Pomarol-Clotet, E., Ciullo, V., Piras, F., Vecchio, D., Banaj, N., Spalletta, G., Michielse, S., van Amelsvoort, T., Dickie, E. W., Voineskos, A. N., Sim, K., Ciufolini, S., Dazzan, P., Murray, R. M., Kim, W-S., Chung, Y-C., Andreou, C., Schmidt, A., Borgwardt, S., McIntosh, A. M., Whalley, H. C., Lawrie, S. M., du Plessis, S., Luckhoff, H. K., Scheffler, F., Emsley, R., Grotegerd, D., Lencer, R., Dannlowski, U., Edmond, J. T., Rootes-Murdy, K., Stephen, J. M., Mayer, A. R., Antonucci, L. A., Fazio, L., Pergola, G., Bertolino, A., Díaz-Caneja, C. M., Janssen, J., Lois, N. G., Arango, C., Tomyshev, A. S., Lebedeva, I., Cervenka, S., Sellgren, C. M., Georgiadis, F., Kirschner, M., Kaiser, S., Hajek, T., Skoch, A., Spaniel, F., Kim, M., Kwak, Y. B., Oh, S., Kwon, J. S., James, A., Bakker, G., Knöchel, C., Stäblein, M., Oertel, V., Uhlmann, A., Howells, F. M., Stein, D. J., Temmingh, H. S., Diaz-Zuluaga, A. M., Pineda-Zapata, J. A., López-Jaramillo, C., Homan, S., Ji, E., Surbeck, W., Homan, P., Fisher, S. E., Franke, B., Glahn, D. C., Gur, R. C., Hashimoto, R., Jahanshad, N., Luders, E., Medland, S. E., Thompson, P. M., Turner, J. A., van Erp, T. G. M. & Francks, C., 4 Apr 2023, In: Proceedings of the National Academy of Sciences of the United States of America. 120, 14, p. e2213880120 e2213880120.

    Research output: Contribution to journalArticleAcademicpeer-review

  7. Speech Illusions in People at Clinical High Risk for Psychosis Linked to Clinical Outcome

    EU-GEI High Risk Study, 15 Mar 2023, In: Schizophrenia bulletin. 49, 2, p. 339-349 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  8. Feasibility and Effect of Increasing Clozapine Plasma Levels in Long-Stay Patients with Treatment-Resistant Schizophrenia

    Bogers, J. P. A. M., Schulte, P. F. J., Broekman, T. G. & de Haan, L., 1 Mar 2023, In: Journal of clinical psychopharmacology. 43, 2, p. 97-105 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  9. The substantia nigra in the pathology of schizophrenia: A review on post-mortem and molecular imaging findings

    van Hooijdonk, C. F. M., van der Pluijm, M., Bosch, I., van Amelsvoort, T. A. M. J., Booij, J., de Haan, L., Selten, J-P. & Giessen, E. V. D., 1 Mar 2023, In: European neuropsychopharmacology. 68, p. 57-77 21 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

  10. The substantia nigra in the pathology of schizophrenia: A review on post-mortem and molecular imaging findings

    van Hooijdonk, C. F. M., van der Pluijm, M., Bosch, I., van Amelsvoort, T. A. M. J., Booij, J., de Haan, L., Selten, J-P. & Giessen, E. V. D., Mar 2023, In: European neuropsychopharmacology. 68, p. 57-77 21 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

Previous 1 2 3 4 5 6 7 8 ...64 Next

ID: 49438